{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:26:38Z","timestamp":1787837198780,"version":"build-2784847793"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00198-012-1970-5","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T19:11:51Z","timestamp":1335294711000},"page":"467-476","source":"Crossref","is-referenced-by-count":18,"title":["Fracture rate in patients with myasthenia gravis: the general practice research database"],"prefix":"10.1007","volume":"24","author":[{"given":"S.","family":"Pouwels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. K.","family":"Javaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hilton-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Verschuuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. G.","family":"Leufkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,25]]},"reference":[{"issue":"9274","key":"1970_CR1","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","volume":"357","author":"A Vincent","year":"2001","unstructured":"Vincent A, Palace J, Hilton-Jones D (2001) Myasthenia gravis. Lancet 357(9274):2122\u20132128","journal-title":"Lancet"},{"key":"1970_CR2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","volume":"10","author":"AS Carr","year":"2010","unstructured":"Carr AS, Cardwell CR, McCarron PO, McConville J (2010) A systematic review of population based epidemiological studies in myasthenia gravis. BMC Neurol 10:46","journal-title":"BMC Neurol"},{"issue":"11","key":"1970_CR3","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","volume":"116","author":"BM Conti-Fine","year":"2006","unstructured":"Conti-Fine BM, Milani M, Kaminski HJ (2006) Myasthenia gravis: past, present, and future. J Clin Invest 116(11):2843\u20132854","journal-title":"J Clin Invest"},{"key":"1970_CR4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1750-1172-2-44","volume":"2","author":"VC Juel","year":"2007","unstructured":"Juel VC, Massey JM (2007) Myasthenia gravis. Orphanet J Rare Dis 2:44","journal-title":"Orphanet J Rare Dis."},{"issue":"5","key":"1970_CR5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1046\/j.1532-5415.2001.49136.x","volume":"49","author":"JK Ngeh","year":"2001","unstructured":"Ngeh JK, McElligott G (2001) Myasthenia gravis: an elusive diagnosis in older people. J Am Geriatr Soc 49(5):683\u2013684","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"1970_CR6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/ageing\/29.1.83","volume":"29","author":"E Chua","year":"2000","unstructured":"Chua E, McLoughlin C, Sharma AK (2000) Myasthenia gravis and recurrent falls in an elderly patient. Age Ageing 29(1):83\u201384","journal-title":"Age Ageing."},{"issue":"9588","key":"1970_CR7","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0140-6736(07)61348-8","volume":"370","author":"A Bhandari","year":"2007","unstructured":"Bhandari A, Adenwalla F (2007) Mysterious falls and a nasal voice. Lancet 370(9588):712","journal-title":"Lancet"},{"key":"1970_CR8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ana.410150316","volume":"15","author":"RM Pascuzzi","year":"1984","unstructured":"Pascuzzi RM, Coslett HB, Johns TR (1984) Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients. Ann Neurol 15:291\u2013298","journal-title":"Ann Neurol"},{"key":"1970_CR9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1212\/WNL.34.2.170","volume":"34","author":"A Sghirlanzoni","year":"1984","unstructured":"Sghirlanzoni A, Peluchetti D, Mantegazza R, Fiacchino F, Cornelio F (1984) Myasthenia gravis: prolonged treatment with steroids. Neurology 34:170\u2013174","journal-title":"Neurology"},{"issue":"3","key":"1970_CR10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2702.2008.02516.x","volume":"18","author":"J K\u00e4llstrand-Ericson","year":"2009","unstructured":"K\u00e4llstrand-Ericson J, Hildingh C (2009) Visual impairment and falls: a register study. J Clin Nurs 18(3):366\u2013372","journal-title":"J Clin Nurs"},{"issue":"1","key":"1970_CR11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jbspin.2010.02.025","volume":"78","author":"RM Pereira","year":"2011","unstructured":"Pereira RM, Freire de Carvalho J (2011) Glucocorticoid-induced myopathy. Joint Bone Spine 78(1):41\u201344","journal-title":"Joint Bone Spine"},{"issue":"8","key":"1970_CR12","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1359\/jbmr.2005.20.8.1486","volume":"20","author":"TP Staa Van","year":"2005","unstructured":"Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2005) Use of oral glucocorticoids and risk of fractures. J Bone Miner Res 20(8):1487\u20131494, discussion 1486","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1970_CR13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/art.22294","volume":"56","author":"F Vries De","year":"2007","unstructured":"De Vries F, Bracke M, Leufkens HG, Lammers JW, Cooper C, Van Staa TP (2007) Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum 56(1):208\u2013214","journal-title":"Arthritis Rheum."},{"issue":"2","key":"1970_CR14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1001\/archneur.60.2.243","volume":"60","author":"MJ Kupersmith","year":"2003","unstructured":"Kupersmith MJ, Latkany R, Homel P (2003) Development of generalized disease at 2\u00a0years in patients with ocular myasthenia gravis. Arch Neurol 60(2):243\u2013248","journal-title":"Arch Neurol"},{"issue":"8","key":"1970_CR15","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1007\/s00415-009-5120-8","volume":"256","author":"MJ Kupersmith","year":"2009","unstructured":"Kupersmith MJ (2009) Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up. J Neurol 256(8):1314\u20131320","journal-title":"J Neurol"},{"issue":"2","key":"1970_CR16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-510X(99)00205-1","volume":"170","author":"JC Keesey","year":"1999","unstructured":"Keesey JC (1999) Does myasthenia gravis affect the brain? J Neurol Sci 170(2):77\u201389","journal-title":"J Neurol Sci"},{"issue":"8","key":"1970_CR17","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1212\/WNL.38.8.1173","volume":"38","author":"DM Tucker","year":"1988","unstructured":"Tucker DM, Roeltgen DP, Wann PD, Wertheimer RI (1988) Memory dysfunction in myasthenia gravis: evidence for central cholinergic effects. Neurology 38(8):1173\u20131177","journal-title":"Neurology"},{"issue":"3","key":"1970_CR18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.bone.2010.06.006","volume":"47","author":"BM Verdel","year":"2010","unstructured":"Verdel BM, Souverein PC, Egberts TC, van Staa TP, Leufkens HG, de Vries F (2010) Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures. Bone 47(3):604\u2013609","journal-title":"Bone"},{"issue":"9","key":"1970_CR19","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1212\/01.wnl.0000210503.89488.88","volume":"66","author":"PC Souverein","year":"2006","unstructured":"Souverein PC, Webb DJ, Weil JG, Van Staa TP, Egberts AC (2006) Use of antiepileptic drugs and risk of fractures: case\u2013control study among patients with epilepsy. Neurology 66(9):1318\u20131324","journal-title":"Neurology"},{"issue":"10","key":"1970_CR20","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s00198-009-0849-6","volume":"20","author":"MW Brand van den","year":"2009","unstructured":"van den Brand MW, Samson MM, Pouwels S, van Staa TP, Thio B, Cooper C, Leufkens HG, Egberts AC, Verhaar HJ, de Vries F (2009) Use of anti-depressants and the risk of fracture of the hip or femur. Osteoporos Int 20(10):1705\u20131713","journal-title":"Osteoporos Int"},{"issue":"9","key":"1970_CR21","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00198-008-0826-5","volume":"20","author":"S Pouwels","year":"2009","unstructured":"Pouwels S, van Staa TP, Egberts AC, Leufkens HG, Cooper C, de Vries F (2009) Antipsychotic use and the risk of hip\/femur fracture: a population-based case\u2013control study. Osteoporos Int 20(9):1499\u20131506","journal-title":"Osteoporos Int"},{"issue":"12","key":"1970_CR22","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/archinte.167.12.1246","volume":"167","author":"EM Haney","year":"2007","unstructured":"Haney EM, Chan BK, Diem SJ, Ensrud KE, Cauley JA, Barrett-Connor E, Orwoll E, Bliziotes MM, Osteoporotic Fractures in Men Study Group (2007) Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med 167(12):1246\u20131251","journal-title":"Arch Intern Med"},{"issue":"12","key":"1970_CR23","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/archinte.167.12.1240","volume":"167","author":"SJ Diem","year":"2007","unstructured":"Diem SJ, Blackwell TL, Stone KL, Yaffe K, Haney EM, Bliziotes MM, Ensrud KE (2007) Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med 167(12):1240\u20131245","journal-title":"Arch Intern Med"},{"key":"1970_CR24","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(97)04248-7","volume":"350","author":"T Walley","year":"1997","unstructured":"Walley T, Mantgani A (1997) The UK General Practice Research Database. Lancet 350:1097\u20131099","journal-title":"Lancet"},{"key":"1970_CR25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/pds.2630030106","volume":"3","author":"TP Staa Van","year":"1994","unstructured":"Van Staa TP, Abenhaim L (1994) The quality of information recorded on a UK database of primary care records: a study of hospitalization due to hypoglycemia and other conditions. Pharmacoepidemiol Drug Saf 3:15\u201321","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1970_CR26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/1099-1557(200009\/10)9:5<359::AID-PDS507>3.0.CO;2-E","volume":"9","author":"TP Staa Van","year":"2000","unstructured":"Van Staa TP, Abenhaim L, Cooper C, Begaud B, Zhang B, Leufkens HG (2000) The use of a large pharmaco-epidemiological database to study exposure to oral glucocorticoids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Saf 9:359\u2013366","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"1970_CR27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0003-4975(00)01595-2","volume":"70","author":"JA Jaretzki 3rd","year":"2000","unstructured":"Jaretzki JA 3rd, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, Sanders DB (2000) Myasthenia gravis: recommendations for clinical research standards. Task force of the medical scientific advisory board of the Myasthenia Gravis Foundation of America. Ann Thorac Surg 70(1):327\u2013334","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"1970_CR28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19(4):385\u2013397","journal-title":"Osteoporos Int"},{"issue":"4","key":"1970_CR29","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.febslet.2010.01.001","volume":"584","author":"T Sata","year":"2010","unstructured":"Sata T, Abe T, Chida D, Nakamoto N, Hori N, Kokabu S, Sakata Y, Tomaru Y, Iwata T, Usui M, Aiko K, Yoda T (2010) Functional role of acetylcholine and the expression of cholinergic receptors and components in osteoblasts. FEBS Lett 584(4):817\u2013824","journal-title":"FEBS Lett"},{"issue":"2","key":"1970_CR30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00441-009-0871-1","volume":"338","author":"M En-Nosse","year":"2009","unstructured":"En-Nosse M, Hartmann S, Trinkaus K, Alt V, Stigler B, Heiss C, Kilian O, Schnettler R, Lips KS (2009) Expression of non-neuronal cholinergic system in osteoblast-like cells and its involvement in osteogenesis. Cell Tissue Res 338(2):203\u2013215","journal-title":"Cell Tissue Res."},{"issue":"2","key":"1970_CR31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.clineuro.2003.12.001","volume":"106","author":"N Wakata","year":"2004","unstructured":"Wakata N, Nemoto H, Sugimoto H, Nomoto N, Konno S, Hayashi N, Araki Y, Nakazato A (2004) Bone density in myasthenia gravis patients receiving long-term prednisolone therapy. Clin Neurol Neurosurg 106(2):139\u2013141","journal-title":"Clin Neurol Neurosurg"},{"key":"1970_CR32","doi-asserted-by":"crossref","first-page":"b4229","DOI":"10.1136\/bmj.b4229","volume":"339","author":"J Hippisley-Cox","year":"2009","unstructured":"Hippisley-Cox J, Coupland C (2009) Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ 339:b4229","journal-title":"BMJ"},{"issue":"1\u20132","key":"1970_CR33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jneuroim.2010.04.017","volume":"225","author":"K Iwasa","year":"2010","unstructured":"Iwasa K, Kato-Motozaki Y, Furukawa Y, Maruta T, Ishida C, Yoshikawa H, Yamada M (2010) Up-regulation of MHC class I and class II in the skeletal muscles of myasthenia gravis. J Neuroimmunol 225(1\u20132):171\u2013174, Epub 2010 May 23","journal-title":"J Neuroimmunol"},{"issue":"6","key":"1970_CR34","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00198-005-0065-y","volume":"17","author":"P Vestergaard","year":"2006","unstructured":"Vestergaard P, Rejnmark L, Moskilde L (2006) Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int 17(6):807\u2013816","journal-title":"Osteoporos Int"},{"key":"1970_CR35","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJM199809243391303","volume":"339","author":"PB Thapa","year":"1998","unstructured":"Thapa PB, Gideon P, Cost TW, Milam AB, Ray WA (1998) Antidepressants and the risk of falls among nursing home residents. N Engl J Med 339:875\u2013882","journal-title":"N Engl J Med"},{"issue":"10","key":"1970_CR36","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1046\/j.1532-5415.2002.50453.x","volume":"50","author":"KE Ensrud","year":"2002","unstructured":"Ensrud KE, Blackwell TL, Mangione CM, Bowman PJ, Whooley MA, Bauer DC, Schwartz AV3, Hanlon JT, Nevitt MC (2002) Study of Osteoporotic Fractures Research Group. Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc 50(10):1629\u20131637","journal-title":"J Am Geriatr Soc"},{"key":"1970_CR37","first-page":"386","volume":"12","author":"WA Ray","year":"1992","unstructured":"Ray WA (1992) Psychotropic drugs and injuires among the elderly: a review. J Clin Psychopharmacol 12:386\u2013396","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"1970_CR38","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJM199601183340308","volume":"334","author":"MJ Brodie","year":"1996","unstructured":"Brodie MJ, Dichter MA (1996) Antiepileptic drugs. N Engl J Med 334(3):168\u2013175","journal-title":"N Engl J Med"},{"key":"1970_CR39","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/archinte.167.12.1246","volume":"167","author":"EM Haney","year":"2007","unstructured":"Haney EM, Chan BK, Diem SJ, Ensrud KE, Cauley JA, Barrett-Connor E et al (2007) Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med 167:1246\u20131251","journal-title":"Arch Intern Med"},{"key":"1970_CR40","first-page":"291","volume":"2","author":"M Bliziotes","year":"2002","unstructured":"Bliziotes M, Gunness M, Eshleman A, Wiren K (2002) The role of dopamine and serotonin in regulating bone mass and strength: studies on dopamine and serotonin transporter null mice. J Musculoskelet Neuronal Interact 2:291\u2013295","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"12","key":"1970_CR41","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.amjmed.2005.07.033","volume":"118","author":"M Kinjo","year":"2005","unstructured":"Kinjo M, Setoguchi S, Schneeweiss S, Solomon DH (2005) Bone mineral density in subjects using central nervous system-active medications. Am J Med 118(12):1414","journal-title":"Am J Med"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-012-1970-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T17:49:34Z","timestamp":1561657774000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-012-1970-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,25]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["1970"],"URL":"https:\/\/doi.org\/10.1007\/s00198-012-1970-5","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,25]]}}}